| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.82 | 0.001 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.27 | 2e-07 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.23 | 4e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-09 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.22 | 6e-05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0001 |